Suppressors of cytokine signalling (SOCS) in the immune system.
about
Enhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactomeSelective regulatory function of Socs3 in the formation of IL-17-secreting T cellsBlocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infectionInduction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathwayMast cell homeostasis and the JAK-STAT pathwayTwo Drosophila suppressors of cytokine signaling (SOCS) differentially regulate JAK and EGFR pathway activitiesHeterologous expression of the filarial nematode alt gene products reveals their potential to inhibit immune functionNegative regulation of cytokine signaling and immune responses by SOCS proteinsThe Ubiquitination of NF-κB Subunits in the Control of TranscriptionThe Role of Reactive Oxygen Species in Myelofibrosis and Related NeoplasmsIntegrating non-coding RNAs in JAK-STAT regulatory networksShikonin Inhibits Inflammatory Response in Rheumatoid Arthritis Synovial Fibroblasts via lncRNA-NR024118.SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell functionDifferential regulation of SOCS-1 signalling in B and T lymphocytes by hepatitis C virus core proteinSOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune FunctionSOCS2 negatively regulates growth hormone action in vitro and in vivoMPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell CarcinomaGenetic reduction of embryonic leukemia-inhibitory factor production rescues placentation in SOCS3-null embryos but does not prevent inflammatory diseaseTranscriptome profiling of selectively bred Pacific oyster Crassostrea gigas families that differ in tolerance of heat shockInfluenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression.Mechanism of attenuation of leptin signaling under chronic ligand stimulation.Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway.Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells.Intracellular delivery of a cell-penetrating SOCS1 that targets IFN-gamma signaling.The mEPN scheme: an intuitive and flexible graphical system for rendering biological pathways.SOCS3 deletion in T lymphocytes suppresses development of chronic ocular inflammation via upregulation of CTLA-4 and expansion of regulatory T cells.HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1)Differential expression and potential role of SOCS1 and SOCS3 in Wallerian degeneration in injured peripheral nerve.Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans.Podocytes regulate neutrophil recruitment by glomerular endothelial cells via IL-6-mediated crosstalk.Investigation of gene expression in C(2)C(12) myotubes following simvastatin application and mechanical strain.Therapeutic HPV DNA vaccines.Interferons and their stimulated genes in the tumor microenvironmentEffects of resistance training on the inflammatory response.Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasmGene Expression Profiles from Peripheral Blood Mononuclear Cells Are Sensitive to Short Processing DelaysProgrammed death-1 affects suppressor of cytokine signaling-1 expression in T cells during hepatitis C infection.Single blastomere removal from murine embryos is associated with activation of matrix metalloproteinases and Janus kinase/signal transducers and activators of transcription pathways of placental inflammation.Suppressor of cytokine signaling 1 interacts with oncogenic lymphocyte-specific protein tyrosine kinase.Toll-like receptor 4 and myeloid differentiation factor 88 provide mechanistic insights into the cause and effects of interleukin-6 activation in mouse liver regeneration.
P2860
Q24294625-7B6435C7-F0C0-4052-9708-53DB0F5B1B81Q24547568-0E3C826D-6D98-4BD1-A8B5-4477004901C9Q24562957-939EF65F-02F4-4ECC-AF09-A9232EAFFB28Q24563231-46FD95FC-FF3E-4094-9FE1-CB21A226EE70Q24632515-2BB44A25-01BE-418F-B963-CE6373D8181BQ24792628-8AFE2DB6-DB31-4B78-BF77-D9985149EF3DQ24806140-F94B67BF-9CA0-4D79-8D41-A8E8970DE0FBQ24816896-51E92739-E56A-4321-BF80-8EAE97AAEAA3Q26748938-89A0F883-591F-4F83-AAFC-6CD58D156E92Q26779929-DA341996-DC2B-4C02-A243-BCE7EC3AA7ABQ26863279-4DD19248-FEC0-4629-B446-1D028C6C01E1Q27315137-58002BEA-6CF2-4EE2-A558-75E26FA6339BQ27472767-94070EFE-F042-46B1-913A-A5C15B92C216Q27487006-7279101A-CA96-46A1-B941-D868B437E246Q28086933-D103C8F2-C46E-42C5-8134-58CFA09DBF43Q28508170-6120290B-2A77-4F05-A568-D5D92DAC11C7Q28552305-99B1DB4E-6750-4685-A5A5-25C5F1E26554Q28592478-AC3061E2-ED4A-40CE-973D-4CE8EA9A45F3Q30494811-4670562B-02E5-4F21-AC0D-18280688EFC6Q33383235-43BA993D-06B3-41FE-9BCE-FDCEBDBB19F0Q33522778-AF9C4445-AF36-408E-8E93-4FE9467202FBQ33553780-4A4F5E9C-4E49-48D1-A33F-97E7CD44A9BBQ33557548-FC9193BA-2021-4301-ABD1-C2125FC8994EQ33560131-361E3651-1D9F-4F80-BE19-608052458AD8Q33579507-CBED1317-38E8-4579-A10B-3625A37494BFQ33697768-3EC94208-1B6E-4E66-BDA7-BD16CD16F864Q33747593-AA6E82E9-081F-4F95-950B-E0D88C21310AQ33771100-341FD448-EE1B-4F81-A8ED-AA604867D04DQ33788125-F310959E-EAD3-4272-931E-971D4A49AE3AQ33795810-2A0F8E7E-FF5B-4138-ACD5-1714FF5F6088Q33837541-DEBC94B6-60C3-4B7C-8CE2-18608B5594CFQ33936427-195EBFDB-CAD5-45D5-99E7-50A38A2DF2BCQ33988567-E01E23F9-1363-4316-8908-6EC226F5731CQ34104494-8BDB5F02-10C8-4EE4-A5DA-BC7CD0464419Q34154772-CE8DFA66-4666-4DC4-8FD2-3FB140A5D83EQ34199302-0AFB29A6-2190-4885-8C2D-A332857EB7B1Q34259893-1AB2425F-F381-496C-86DD-CCBC8944E886Q34532628-AFF6571E-8FE5-47C2-99B3-A2C2282FAF3AQ34543450-453D0A41-0CC3-4D64-A74B-659CD7EE24FDQ34587841-E7ED02B7-2FE6-427F-A297-8FDB1F8BE26C
P2860
Suppressors of cytokine signalling (SOCS) in the immune system.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Suppressors of cytokine signalling (SOCS) in the immune system.
@ast
Suppressors of cytokine signalling (SOCS) in the immune system.
@en
type
label
Suppressors of cytokine signalling (SOCS) in the immune system.
@ast
Suppressors of cytokine signalling (SOCS) in the immune system.
@en
prefLabel
Suppressors of cytokine signalling (SOCS) in the immune system.
@ast
Suppressors of cytokine signalling (SOCS) in the immune system.
@en
P356
P1476
Suppressors of cytokine signalling (SOCS) in the immune system.
@en
P2093
Warren S Alexander
P304
P356
10.1038/NRI818
P577
2002-06-01T00:00:00Z